BOND ORACLE HER2 IHC SYSTEM

System, Test, Her-2/neu, Ihc

FDA Premarket Approval P090015 S004

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Transfer of several items of equipment from one testing laboratory to another laboratory within the same manufacture site. The equipment is used to complete the quality control testing of the bond oracle her2 ihc system.

DeviceBOND ORACLE HER2 IHC SYSTEM
Classification NameSystem, Test, Her-2/neu, Ihc
Generic NameSystem, Test, Her-2/neu, Ihc
ApplicantLeica Biosystems
Date Received2017-02-02
Decision Date2017-02-15
PMAP090015
SupplementS004
Product CodeMVC
Advisory CommitteePathology
Supplement Type30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product Yes
Applicant Address Leica Biosystems 36 Cherry Hill Drive danvers, MA 01923

Supplemental Filings

Supplement NumberDateSupplement Type
P090015Original Filing
S012 2020-08-28 30-day Notice
S011 2020-04-02 30-day Notice
S010 2019-12-13 30-day Notice
S009 2019-09-09 30-day Notice
S008 2019-07-24 30-day Notice
S007 2019-04-01 30-day Notice
S006 2018-10-26 Real-time Process
S005 2017-06-27 30-day Notice
S004 2017-02-02 30-day Notice
S003 2015-04-20 Special (immediate Track)
S002 2014-11-28 Real-time Process
S001 2013-07-26 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.